Oct 11, 2024, 08:15
Managing ADC Toxicities on Lung Cancer Considered
“Anti Drug Conjugates represent a new way of treating thoracic, breast and gastrointestinal cancers.
Despite recent successes, many ADCs failed during clinical development due to excessive toxicities and unfavorable risk-benefit profiles.
In this episode of Lung Cancer Considered, host Narjust Florez discusses ADCs, and how clinicians can manage some of these toxicities.
With Benjamin Levy and Paolo Tarantino.”
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 20, 2024, 20:38
Nov 20, 2024, 20:27
Nov 20, 2024, 19:12
Nov 20, 2024, 19:12
Nov 20, 2024, 19:12
Nov 20, 2024, 19:12